Merck nears US$10 billion deal for London-based lung therapy firm Verona, FT reports
Merck is nearing a US$10 billion deal to buy lung diseases focussed Verona Pharma, as the US drugmaker is eyeing ...
Merck is nearing a US$10 billion deal to buy lung diseases focussed Verona Pharma, as the US drugmaker is eyeing ...
A Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced ...
Reuters KEY POINTSDoctors found a hole on his lung, which they said was caused by inhaling a harmful chemical substanceThe ...
AstraZeneca has developed a new pill that significantly reduces the chances of death from lung cancer. The drug named osimertinib ...
British band Coldplay announced Tuesday that it is postponing some of its upcoming shows for its "Music of the Spheres" ...
KEY POINTSThe EGFR gene and the KRAS gene have been linked to lung cancerExposure to PM2.5 pollution particles increased the ...
International Business Weekly is an American entertainment magazine. We cover business News & feature exclusive interviews with many notable figures
Copyright © 2024 - International Business Weekly